Reaction Details |
| Report a problem with these data |
Target | Coagulation factor XI |
---|
Ligand | BDBM285879 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Factor XIa Assay |
---|
pH | 7.4±n/a |
---|
IC50 | 7.65±n/a nM |
---|
Comments | extracted |
---|
Citation | Mertz, E; Edmondson, SD; So, S; Sun, W; Liu, W; Neelamkavil, SF; Gao, Y; Hruza, A; Zang, Y; Ali, A; Mal, R; He, J; Kuang, R; Wu, H; Ogawa, AK; Nolting, AF Factor XIa inhibitors US Patent US10081617 Publication Date 9/25/2018 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Coagulation factor XI |
---|
Name: | Coagulation factor XI |
Synonyms: | Coagulation factor XIa | Coagulation factor XIa heavy chain | Coagulation factor XIa light chain | F11 | FA11_HUMAN | FXI | Factor XIa | Factor XIa (fXIa) | PTA | Plasma thromboplastin antecedent |
Type: | Enzyme |
Mol. Mass.: | 70130.58 |
Organism: | Homo sapiens (Human) |
Description: | P03951 |
Residue: | 625 |
Sequence: | MIFLYQVVHFILFTSVSGECVTQLLKDTCFEGGDITTVFTPSAKYCQVVCTYHPRCLLFT
FTAESPSEDPTRWFTCVLKDSVTETLPRVNRTAAISGYSFKQCSHQISACNKDIYVDLDM
KGINYNSSVAKSAQECQERCTDDVHCHFFTYATRQFPSLEHRNICLLKHTQTGTPTRITK
LDKVVSGFSLKSCALSNLACIRDIFPNTVFADSNIDSVMAPDAFVCGRICTHHPGCLFFT
FFSQEWPKESQRNLCLLKTSESGLPSTRIKKSKALSGFSLQSCRHSIPVFCHSSFYHDTD
FLGEELDIVAAKSHEACQKLCTNAVRCQFFTYTPAQASCNEGKGKCYLKLSSNGSPTKIL
HGRGGISGYTLRLCKMDNECTTKIKPRIVGGTASVRGEWPWQVTLHTTSPTQRHLCGGSI
IGNQWILTAAHCFYGVESPKILRVYSGILNQSEIKEDTSFFGVQEIIIHDQYKMAESGYD
IALLKLETTVNYTDSQRPICLPSKGDRNVIYTDCWVTGWGYRKLRDKIQNTLQKAKIPLV
TNEECQKRYRGHKITHKMICAGYREGGKDACKGDSGGPLSCKHNEVWHLVGITSWGEGCA
QRERPGVYTNVVEYVDWILEKTQAV
|
|
|
BDBM285879 |
---|
n/a |
---|
Name | BDBM285879 |
Synonyms: | US10081617, Example 27 | US10081617, Example 28 | methyl [4-(2-{3-[5-chloro- 2-(1H-tetrazol-1- yl)phenyl]-7-methoxy-1- oxido-6,7-dihydro-5H- cyclopenta[b]pyridin-7-yl}- 1H-imidazol-5- yl)phenyl]carbamate |
Type | Small organic molecule |
Emp. Form. | C27H23ClN8O4 |
Mol. Mass. | 558.976 |
SMILES | COC(=O)Nc1ccc(cc1)-c1cnc([nH]1)C1(CCc2cc(c[n+]([O-])c12)-c1cc(Cl)ccc1-n1cnnn1)OC |
Structure |
|